Title

Evaluating treatments for Ménière's disease: controversies surrounding placebo control.

Authors

Teri A Hamill

ISBN or ISSN

10500545

Volume

17

Issue

1

Publication Date / Copyright Date

1-1-2006

First Page

27

Last Page

37

DOI Number

https://doi.org/10.3766/jaaa.17.1.4

Abstract

Although double-blind experimental designs are considered the gold standard for documenting treatment effectiveness, many treatments for Ménière's disease have not been evaluated using this methodology. Particularly with a disease characterized by exacerbation and remission, carefully controlled, long-term studies are required. The nature of the placebo effect is described in this article, and the concept of debonafide effect introduced. Ideally, patients should be given treatments supported by evidence-based medicine that have the lowest possible risk of side effects. However, risk minimization may dictate using treatments that have not been proven effective and may evoke debonafide effects.

Disciplines

Medicine and Health Sciences

Keywords

Double-Blind Method, Ear, Inner, Endolymphatic Sac, Humans, Injections, Intralesional, Meniere Disease, Middle Ear Ventilation, Placebo Effect, Randomized Controlled Trials as Topic, Treatment Outcome, Tympanic Membrane

This document is currently not available here.

Find in your library

Share

 
COinS